PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAF1. A total of 20 filers reported holding PDL BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $43,715,000 | -0.0% | 43,840,000 | 0.0% | 1.64% | -0.4% |
| Q3 2017 | $43,727,000 | +0.2% | 43,840,000 | 0.0% | 1.65% | -18.8% |
| Q2 2017 | $43,635,000 | +0.5% | 43,840,000 | 0.0% | 2.03% | +3.4% |
| Q1 2017 | $43,420,000 | -49.2% | 43,840,000 | -50.0% | 1.96% | -8.4% |
| Q4 2016 | $85,464,000 | +120.6% | 87,680,000 | +120.1% | 2.14% | -9.6% |
| Q3 2016 | $38,744,000 | +37.1% | 39,840,000 | +33.4% | 2.37% | +28.0% |
| Q2 2016 | $28,251,000 | +51.2% | 29,875,000 | +44.5% | 1.85% | +4.0% |
| Q1 2016 | $18,682,000 | – | 20,675,000 | – | 1.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|